Pharmaceuticals and Biotech

Upcoming Conferences


EU Pharma Law & Regulation Feb 22 - 23, 2012 London In times of growing competition with tighter healthcare budgets, of stricter national pricing and reimbursement laws and increased scrutiny from the regulators, it is – now more than ever – crucial for the legal team to keep abreast with regulatory developments as well as benchmark against pharma industry best practice. 14 senior in-house experts will address the main challenges for 2012: • How to establish a successful Pricing & Reimbursement Strategy • Manage the risks of advertising, social media and off-label promotion • Strategies to maximize your patent portfolio by taking into account the latest SPCs decisions for orphan, paediatrics and fixed-dose combination products • Competition law developments and recent case law, particularly with regards to reverse settlements Plus hear from the MHRA on the latest Pharmacovigilance implementation efforts and regulatory expectations . [Tags: Pharma Conference, Regulatory Compliance Conference]
Biotech Patenting Mar 14 - 15, 2012 Munich 2012 Munich Biotech Patenting forum will focus on latest legal developments affecting biotech companies, with a particular focus on successful techniques and strategies for drafting and filing patent applications in multiple jurisdictions. Providing a unique opportunity for you to network with your fellow industry peers, key industry regulators and expert patent attorneys from across globe, allowing you to develop your current biotech practices and remain competitive in today’s ever-changing and ever-expanding market.
Freedom to Operate May 09 - 10, 2012 Frankfurt The 2012 Forum will focus on all aspects of FTO, including best practice advice how to conduct more time and cost effective FTO searches, interpreting the results and developing strategies to overcome blocking patents, quantifying FTO risks and finally writing successful FTO opinions.
Pharma Patent Lifecycles Jun 20 - 21, 2012 London Patent lifecycle management is becoming more crucial for pharmaceutical companies with the cost of research and drugs continually rising and companies constantly trying to obtain the maximum financial benefit from existing patent terms. In addition to protecting existing IP rights and seeking methods to extend current patent lifecycles, pharmaceutical companies are faced with the challenge of inventing new drugs and diversifying portfolios to replace sales on older and generic drugs.

LinkedIn Testimonials

Julian Hitchcock, Director at CellFate
United Kingdom
I echo the remarks made by colleagues. A very high standard indeed; well focused and authoritative.
- September 20, 2011
Iain Armstrong, Patent Director at Harrison Goddard Foote
Manchester, United Kingdom
C5 produces well thought out conferences with speakers from a range of backgrounds providing useful information from a number of different perspectives. The conferences are well attended, and provide an excellent chance to network with both delegates and speakers.
- August 3, 2011
Sally Shorthose, Partner at Bird & Bird (law firm)
London, United Kingdom
Always well organised and with "clout" to attract high quality speakers and delegated. They go to great lengths to ensure presentations are relevant, of interst and up to date.
- April 1, 2011
Rob Fitt, Senior Associate at Bristows
United Kingdom
Very well attended conferences with high quality presentations from impressive panels of speakers.
- March 15, 2011
Kristina Cornish, Owner at Kilburn & Strode
United Kingdom
These conferences provide an excellent combination of education and networking. They are truly "international". I recommend attending.
- February 28, 2011
Anna Dibell, ICC Coach & Business Consultant at Purpureus
Malmö Area, Sweden
I attended the eCTD Summit in September 2010. A great way to keep updated and to share knowledge and experience with colleagues and key players from both industry and authorities.
- February 24, 2011
Cyra Nargolwalla, Owner at Cabinet Plasseraud
Paris Area, France
I have always enjoyed attending and speaking at C5 IP conferences for a number of reasons: the organization is impeccable, the topics are timely and relevant, the speakers and attendees hail from a wide variety of backgrounds and so have much to share. All in all, a very successful mix!
- February 24, 2011
Eric Steffe, Director at Sterne, Kessler, Goldstein & Fox
Washington D.C. Metro Area
The C5 Pharma/BioPharma IP conferences are worth the time committment. They provide an international perspective to a rapidly evolving field where IP is of paramount importance.
- February 23, 2011
David Resnick, Co-Leader, Patent Group/Leader, Biotechnology/Chemistry Team, Partner at Nixon Peabody LLP
Greater Boston Area
I attended two C5 Biotech conferences. Both conferences were excellent. I came away with a better understanding of issues unique to the European patent system. I also met a number of friends and business contacts, several of which I now work with on a regular basis.
- February 18, 2011
Marianne Schaffner, Partner at Linklaters
Paris Area, France
Very well organised conferences as a speaker and as an attendee. C5 focuses on strategic topics with the aim of meeting the pharma business needs. The pragmatic approach has to be underlined.
- February 17, 2011
,
The conference was informative, but it also demonstrated the knack of making an event conducive to quality interactions.
- January 24, 2011
Alain Seront, Manager of the Document Management and Publishing Team at GlaxoSmithKline Biologicals
Charleroi Area, Belgium
I attended the "Successful Lifecycle Management of the eCTD" C5 Conference: key players in the industry were presents and provided valuable information about the last updates in the field of electronic submissions, and a good view of what the future will look like.
- January 24, 2011
Mark Einerhand, European Patent Attorney, Partner at Vereenigde
Utrecht Area, Netherlands
The C5s Biotech Patenting Conferences are for me the best way to get updated on the latest developments in the Biotech IP field. The presentations cover a lot of ground but are also concise and to the point. They provide the necessary background and the hands-on information that can be applied immediately in every day practice.
- January 24, 2011
Rana Gosain, Partner at Daniel Advogados
Brazil
Well-organized, informative conference; speakers with diverse viewpoints and perspectives; good opportunities for networking with attendees from various backgrounds"
- January 24, 2011